4598 — Delta-Fly Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Delta-Fly Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -964 | -1,326 | -1,427 | -1,719 | -1,623 |
| Depreciation | |||||
| Non-Cash Items | 1.39 | 7.59 | 18.7 | 9.42 | 17.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 20.6 | 13.5 | 127 | -127 | 47.4 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -940 | -1,303 | -1,280 | -1,835 | -1,557 |
| Capital Expenditures | — | -0.321 | -1.13 | -0.116 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.005 | 1.34 | -0.09 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.326 | 0.207 | -0.206 | — |
| Financing Cash Flow Items | — | 3.97 | 503 | 2.12 | 3.63 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 120 | 883 | 1,853 | 757 | 1,364 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -820 | -424 | 573 | -1,078 | -193 |